Clinical trial
Micellar Paclitaxel to Treat Severe Psoriasis
NCT00006276 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00006276 |
|---|---|
| Title | Micellar Paclitaxel to Treat Severe Psoriasis |
| Official title | A Pilot Open-Label Single-Dose Study Using Intravenous Micellar Paclitaxel for Patients With Severe Psoriasis |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Micellar Paclitaxel |
| Enrollment | 25 |
| Start date | Sep 1, 2000 |
| Completion | Oct 1, 2002 |
| First posted | Sep 15, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: